Search
for
Sort by
Research 91–120 of 1000+
- JAK1 Signaling Is Involved in the Induction of Mechanical Alloknesis in Atopic Dermatitis
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- The role of janus kinases in the treatment of autoimmune skin diseases
- Keratin 6A promotes skin inflammation through JAK1-STAT3 activation in keratinocytes
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia
- INVESTIGATING THE MECHANISMS UNDERLYING THE PATHOGENESIS OF ALOPECIA AREATA
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series
- Review of Promising Off-Label Use of Deucravacitinib
- Poster Presentations
- The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
- Janus kinase inhibitors for alopecia areata: A narrative review
- Comparative analysis of therapeutic outcomes in pediatric versus adult ophiasis-pattern alopecia areata: A review of treatment modalities and disease course
- Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
- Upadacitinib for the Management of Alopecia Totalis and Subtotalis in Pediatric Patients: A Case Series
- A phase 2a trial of brepocitinib for cicatricial alopecia
- Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib
- Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up
- Delayed granulomatous eruption of the nose associated with ruxolitinib
- Oclacitinib Treatment and Surgical Management in a Case of Periocular Eosinophilic Furunculosis and Vasculitis with Secondary Eyelid Fusion in a Diabetic Cat
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- Ruxolitinib protects skin stem cells and maintains skin homeostasis in murine graft-versus-host disease
- Comparison of Current International Guidelines for the Management of Alopecia Areata—Comprehensive Review
- Good efficacy achieved by telitacicept in treatment of systemic lupus erythematosus with alopecia areata
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Case Report: Repigmentation and complete hair regrowth in an 11-year-old preadolescent with alopecia totalis treated with a JAK inhibitor
- TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen Planopilaris